For example, the humanized anti-VEGF-A antibody Avastin was tested in combination with conventional chemotherapies or radiotherapy for several tumor entities and it became more evident that the success of antiangiogenic treatment with VEGF blockade was highly dependent on the tumor type. This evidence concerns the gene VEGFA and neoplasm.